Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.75−0.18 (-0.64%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Zenas BioPharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Zenas BioPharma's profit margin for the twelve months ending Dec 31, 2025 was -3777.4%. For fiscal 2025 it was -3777.4%, against -3139.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3777.4% | −637.6 |
| FY2024 | Dec 31, 2024 | -3139.8% | −3065.5 |
| FY2023 | Dec 31, 2023 | -74.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -1089.2% | −1160.4 |
| Q2 FY2026 | Jun 30, 2026 | -11145.6% | – |
| Q1 FY2025 | Mar 31, 2025 | -335.7% | – |
| Q4 FY2024 | Dec 31, 2024 | -1052.1% | – |
| Q3 FY2023 | Sep 30, 2023 | 71.2% | – |
See a number that looks wrong?